Scientists had tried to treat diseases by editing genes since the 1990s, but the methods were cumbersome and didn’t pay off. Then in June 2012, the journal Science published a paper by two future ...

The FDA late last week set for December a groundbreaking decision on whether to grant its first-ever approval for a CRISPR-Cas9 gene-edited therapy—but the milestone so far doesn’t seem to be wowing ...